摘要 |
<p>The object is to synthesize a novel 1,2,3,4-tetrahydroquinoxaline derivative represented by the formula (1) and find a pharmacological activity of the derivative: (1) wherein R<SUP>1</SUP> represents a halogen, an alkyl, cycloalkyl, aryl or heterocyclic group, or the like; p represents 0 to 5; R<SUP>2</SUP> represents a halogen, an alkyl, hydroxyl or alkoxy group, or the like; q represents 0 to 2; R<SUP>3</SUP> represents a hydrogen, an alkyl, alkenyl, alkylcarbonyl or arylcarbonyl group, or the like; R<SUP>4</SUP> and R<SUP>5</SUP> independently represent a hydrogen, a halogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; R<SUP>6</SUP> represents a hydrogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; A represents an alkylene; R<SUP>7</SUP> represents OR<SUP>8</SUP>, NR<SUP>8</SUP>R<SUP>9</SUP>, SR<SUP>8</SUP>, S(O)R<SUP>8</SUP>, S(O)<SUB>2</SUB>R<SUP>8</SUP>; and X represents O or S.</p> |
申请人 |
SANTEN PHARMACEUTICAL CO., LTD.;MATSUDA, MAMORU;MORI, TOSHIYUKI;KAWASHIMA, KENJI;YAMAMOTO, MINORU;KATO, MASATOMO;TAKAI, MIWA;NAGATSUKA, MASATO;KOBAYASHI, SACHIKO |
发明人 |
MATSUDA, MAMORU;MORI, TOSHIYUKI;KAWASHIMA, KENJI;YAMAMOTO, MINORU;KATO, MASATOMO;TAKAI, MIWA;NAGATSUKA, MASATO;KOBAYASHI, SACHIKO |